A fabulous narrative of twists and turns and collaborations across multiple nonprofit institutions, companies, governments. As we debate drug pricing and R/D timelines, often cynically, this is a nice example of staying focused on the problem and bringing assets together for a solution. Well done! Great read to start 2020.
Also in Industry News
How to decide whether or not to start treatment for prostate cancer?
Analysis of the SARS-CoV-2 proteome via visual tools
$65m investment increases British Patient Capital’s exposure to life sciences and health technology